Related references
Note: Only part of the references are listed.Population-based survival for malignant mesothelioma after introduction of novel chemotherapy
Ronald A. M. Damhuis et al.
EUROPEAN RESPIRATORY JOURNAL (2012)
Malignant Mesothelioma: Facts, Myths, and Hypotheses
Michele Carbone et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2012)
Intraperitoneal distribution imaging in ovarian cancer patients
S. J. Dawson et al.
INTERNAL MEDICINE JOURNAL (2011)
Computed tomographic peritoneography prior to intraperitoneal chemotherapy in advanced mullerian cancer: a pilot study
Joyce N. Barlin et al.
CLINICAL IMAGING (2010)
Two-stage operative cytoreduction and intraperitoneal chemotherapy for diffuse malignant peritoneal mesothelioma: Operative morbidity and mortality in phase I and II trials
M. D. Kluger et al.
EJSO (2010)
Time trend of mesothelioma incidence in the United States and projection of future cases: An update based on SEER data for 1973 through 2005
Bertram Price et al.
CRITICAL REVIEWS IN TOXICOLOGY (2009)
Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Malignant Peritoneal Mesothelioma: Multi-Institutional Experience
Tristan D. Yan et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Combined resection, intraperitoneal chemotherapy, and whole abdominal radiation for the treatment of malignant peritoneal mesothelioma
Mary E. Hesdorffer et al.
AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS (2008)
Intraperitoneal cisplatin and paclitaxel in ovarian cancer
DK Armstrong et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Intraperitoneal catheter outcomes in a phase III trial of intravenous versus intrapentoneal chemotherapy in optimal stage III ovarian and primary peritoneal cancer: A Gynecologic Oncology Group study
JL Walker et al.
GYNECOLOGIC ONCOLOGY (2006)
Intraperitoneal carboplatin infusion may be a pharmacologically more reasonable route than intravenous administration as a systemic chemotherapy. A comparative pharmacokinetic analysis of platinum using a new mathematical model after intraperitoneal vs. intravenous infusion of carboplatin - A Sankai Gynecology Study Group (SGSG) study
Y Miyagi et al.
GYNECOLOGIC ONCOLOGY (2005)
Nonpleural mesothelioma: Mesothelioma of the peritoneum, tunica vaginalis, and pericardium
R Hassan et al.
HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA (2005)
Intraperitoneal carboplatin-based chemotherapy for epithelial ovarian cancer
K Fujiwara et al.
GYNECOLOGIC ONCOLOGY (2005)
The transport barrier in intraperitoneal therapy
MF Flessner
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2005)
Analysis of factors associated with outcome in patients with malignant peritoneal mesothelioma undergoing surgical debulking and intraperitoneal chemotherapy
AL Feldman et al.
JOURNAL OF CLINICAL ONCOLOGY (2003)
Intraperitoneal antineoplastic drug delivery: rationale and results
M Markman
LANCET ONCOLOGY (2003)
Factors predicting survival after intraperitoneal hyperthermic chemotherapy with mitomycin C after cytoreductive surgery for patients with peritoneal carcinomatosis
P Shen et al.
ARCHIVES OF SURGERY (2003)
Share Paper
